Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Clinical Pharmacology
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Clinical Pharmacology
    Rituximab May Slow Beta-Cell Destruction in Patients With Type 1 Diabetes - (DGNews)
    Antithrombotic Medication Use Not Improving Among Ischaemic Stroke Survivors - (DGNews)
    Statins May Protect Stem Cell Transplant Recipients From Graft-Versus-Host Disease - (DGNews)
    Breast Gamma Imaging Suggested for Cancer Detection: Presented at RSNA - (DGDispatch)
    Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases - (JAMA)

    News archive

     Recent webcasts/CME - Clinical Pharmacology
      Allergic Rhinitis and the Costs of Undertreatment: A Clinical and Economic Update for Managed Care-Case Vignettes
      Multiple Sclerosis: Tempering Disabilities and Decline--Fundamentals for Managed Markets
      Evolving Strategies for Chronic Idiopathic Thrombocytepenic Purpura
      Advances in the Treatment of NHL: Updates from the 2009 Pan Pacific Lymphoma Conference
      Fibromyalgia: The Patient Who Hurts Too Much

      Webcasts/CME archive

       Recent cases - Clinical Pharmacology
        Ulceration Of The Oral Mucosa Induced By Antidepressant Medication: A Case Report
        Dual Antiplatelet Therapy in Coronary Artery Disease: A Case-Based Approach
        Persistent Orocutaneous and Anal Fistulae Induced by Nicorandil: A Case Report
        Successful Use of Single-Dose Rituximab for the Maintenance of Remission in a Patient with Steroid-Resistant Nephrotic Syndrome
        Recurrent Stupor Associated with Chronic Valproic Acid Therapy and Hyperammonemia

        Cases archive
          




        my personal edition > clinical pharmacology > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Report of H1N1 Cases in California Shows Hospitalisation Can Occur At All Ages

          CHICAGO -- November 3, 2009 -- In contrast with some common perceptions regarding influenza A(H1N1) infections, an examination of cases in California indicates that hospitalisation and death can occur at all ages, and about 30% of hospitalised cases have been severe enough to require treatment in an intensive care unit (ICU), according to a study in the November 4 issue of JAMA.

          Preliminary comparisons with seasonal influenza suggest that H1N1 disproportionately affects younger ages and causes generally mild disease.

          Janice K. Louie, MD, California Department of Public Health, Richmond, California, and colleagues examined the clinical and epidemiologic features of the first 1,088 hospitalised and fatal cases due to H1N1 reported in California between April 23 and August 11, 2009. On April 20, the California Department of Public Health and 61 local health departments initiated enhanced surveillance for hospitalised and fatal cases of H1N1.

          The researchers found that of the 1,088 H1N1 cases, 344 (32%) were children aged younger than 18 years, with infants having the highest rate of hospitalisation and persons aged 50 years or older having the highest rate of death once hospitalised. The median age of all cases was 27 years.

          Fever, cough, and shortness of breath were the most common symptoms. Underlying conditions previously associated with severe influenza were reported in 68% of cases. Other underlying medical illnesses recorded included obesity, hypertension, hyperlipidemia, and gastrointestinal disease. The median length of hospitalisation among all cases was 4 days.

          A total of 340 cases (31%) were admitted to ICUs, and of the 297 intensive care cases with available information, 65% required mechanical ventilation. Of the 884 cases with available information, 79% received antiviral treatment, including 496 patients (71%) with established risk factors for severe influenza. Of the 833 patients who had chest radiographs, 66% had infiltrates, suggestive of pneumonia or acute respiratory distress syndrome. Rapid antigen tests were falsely negative in 34% of cases evaluated.

          "Overall fatality was 11% (118/1,088) and was highest (18-20%) in persons aged 50 years or older," the researchers wrote. "Of the deaths, 8 (7%) were children younger than 18 years. Among fatal cases, the median time from onset of symptoms to death was 12 days." The most common causes of death were viral pneumonia and acute respiratory distress syndrome.

          "In the first 16 weeks of the current pandemic, H1N1 appears to be notably different from seasonal influenza, with fewer hospitalisations and fatalities occurring in elderly persons," they continued. "In contrast with the common perception that H1N1 causes only mild disease, hospitalisation and death occurred at all ages, and up to 30% of hospitalised cases were severely ill. Most hospitalised cases had identifiable established risk factors; obesity may be a newly identified risk factor for fatal H1N1 and merits further study."

          "Clinicians should maintain a high level of suspicion for H1N1 infection in patients presenting currently with influenza-like illness who are older than 50 years or have known risk factors for influenza complications, regardless of rapid test results," they concluded. "Hospitalised infected cases should be carefully monitored and treated promptly with antiviral agents."


          SOURCE: JAMA




        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send